Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial

Abstract Vortioxetine is a multimodal antidepressant, with anxiolytic properties observed in preclinical studies. The goal of the current study was to evaluate the efficacy and tolerability of vortioxetine 5 mg vs placebo in adults with generalized anxiety disorder (GAD). Adults with a primary diagn...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European neuropsychopharmacology 2012-12, Vol.22 (12), p.847-857
Hauptverfasser:	Bidzan, Leszek, Mahableshwarkar, Atul R, Jacobsen, Paula, Yan, Mingjin, Sheehan, David V
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Anti-Anxiety Agents - therapeutic use Antidepressants Anxiety Anxiety Disorders - drug therapy Anxiety Disorders - epidemiology Anxiety Disorders - psychology Anxiolytics Bis-aryl-sulfanylamine Clinical trials Double-Blind Method Female Generalized anxiety disorder (GAD) Glutamate decarboxylase Headache Humans Internal Medicine Internationality Major depressive disorder (MDD) Male Middle Aged Mouth Multimodal Nausea Piperazines - therapeutic use Poland - epidemiology Psychiatry Remission Sodium lauryl sulfate Statistical analysis Sulfides - therapeutic use Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!